Dedicare Inkomsten in het verleden
Verleden criteriumcontroles 3/6
Dedicare has been growing earnings at an average annual rate of 25.9%, while the Healthcare industry saw earnings growing at 20% annually. Revenues have been growing at an average rate of 21.4% per year. Dedicare's return on equity is 23.6%, and it has net margins of 3.7%.
Belangrijke informatie
25.9%
Groei van de winst
25.2%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 8.1% |
| Inkomstengroei | 21.4% |
| Rendement op eigen vermogen | 23.6% |
| Nettomarge | 3.7% |
| Volgende winstupdate | 07 Feb 2025 |
Recente prestatie-updates uit het verleden
There May Be Reason For Hope In Dedicare's (STO:DEDI) Disappointing Earnings
Nov 03
We Think Dedicare's (STO:DEDI) Solid Earnings Are Understated
Feb 16Recent updates
There May Be Reason For Hope In Dedicare's (STO:DEDI) Disappointing Earnings
Nov 03Why Investors Shouldn't Be Surprised By Dedicare AB (publ)'s (STO:DEDI) 43% Share Price Plunge
May 21Dedicare (STO:DEDI) Is Paying Out A Larger Dividend Than Last Year
Apr 25Dedicare (STO:DEDI) Has Announced That It Will Be Increasing Its Dividend To SEK6.50
Feb 22We Think Dedicare's (STO:DEDI) Solid Earnings Are Understated
Feb 16Here's Why We Think Dedicare (STO:DEDI) Might Deserve Your Attention Today
Feb 10What Does Dedicare AB (publ)'s (STO:DEDI) Share Price Indicate?
Oct 26Is Dedicare (STO:DEDI) A Risky Investment?
Apr 10Does Dedicare (STO:DEDI) Deserve A Spot On Your Watchlist?
Oct 22Dedicare (STO:DEDI) Seems To Use Debt Rather Sparingly
Jul 20If You Like EPS Growth Then Check Out Dedicare (STO:DEDI) Before It's Too Late
Jun 04Dedicare (STO:DEDI) Could Be Struggling To Allocate Capital
Mar 17Here's Why We Think Dedicare (STO:DEDI) Is Well Worth Watching
Feb 23I Ran A Stock Scan For Earnings Growth And Dedicare (STO:DEDI) Passed With Ease
Nov 16A Look At The Fair Value Of Dedicare AB (publ) (STO:DEDI)
Oct 27I Ran A Stock Scan For Earnings Growth And Dedicare (STO:DEDI) Passed With Ease
Aug 11Be Wary Of Dedicare (STO:DEDI) And Its Returns On Capital
Jul 17A Look At The Intrinsic Value Of Dedicare AB (publ) (STO:DEDI)
May 04Should Dedicare AB (publ) (STO:DEDI) Be Part Of Your Dividend Portfolio?
Apr 13Dedicare (STO:DEDI) Could Easily Take On More Debt
Mar 29What Do The Returns On Capital At Dedicare (STO:DEDI) Tell Us?
Mar 12Dedicare AB (publ)'s (STO:DEDI) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Feb 22We Think Dedicare's (STO:DEDI) Statutory Profit Might Understate Its Earnings Potential
Feb 02Would Shareholders Who Purchased Dedicare's (STO:DEDI) Stock Three Years Be Happy With The Share price Today?
Jan 14
Would Dedicare AB (publ) (STO:DEDI) Be Valuable To Income Investors?
Dec 27Our Take On The Returns On Capital At Dedicare (STO:DEDI)
Dec 06Opbrengsten en kosten
Hoe Dedicare geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 1,798 | 66 | 200 | 0 |
| 30 Jun 24 | 1,861 | 89 | 191 | 0 |
| 31 Mar 24 | 1,900 | 96 | 200 | 0 |
| 31 Dec 23 | 1,973 | 110 | 200 | 0 |
| 30 Sep 23 | 2,011 | 102 | 56 | 0 |
| 30 Jun 23 | 1,937 | 102 | 204 | 0 |
| 31 Mar 23 | 1,882 | 105 | 140 | 0 |
| 31 Dec 22 | 1,772 | 101 | 180 | 0 |
| 30 Sep 22 | 1,623 | 93 | 55 | 0 |
| 30 Jun 22 | 1,504 | 84 | 36 | 0 |
| 31 Mar 22 | 1,379 | 76 | 18 | 0 |
| 31 Dec 21 | 1,250 | 66 | 0 | 0 |
| 30 Sep 21 | 1,143 | 61 | 139 | 0 |
| 30 Jun 21 | 1,063 | 55 | 114 | 0 |
| 31 Mar 21 | 980 | 42 | 92 | 0 |
| 31 Dec 20 | 885 | 36 | 70 | 0 |
| 30 Sep 20 | 823 | 29 | 62 | 0 |
| 30 Jun 20 | 783 | 23 | 62 | 0 |
| 31 Mar 20 | 762 | 26 | 62 | 0 |
| 31 Dec 19 | 776 | 26 | 62 | 0 |
| 30 Sep 19 | 784 | 28 | 65 | 0 |
| 30 Jun 19 | 794 | 31 | 65 | 0 |
| 31 Mar 19 | 803 | 32 | 65 | 0 |
| 31 Dec 18 | 812 | 38 | 65 | 0 |
| 30 Sep 18 | 812 | 42 | 61 | 0 |
| 30 Jun 18 | 787 | 43 | 61 | 0 |
| 31 Mar 18 | 778 | 50 | 61 | 0 |
| 31 Dec 17 | 785 | 60 | 61 | 0 |
| 30 Sep 17 | 781 | 68 | 53 | 0 |
| 30 Jun 17 | 759 | 72 | 53 | 0 |
| 31 Mar 17 | 716 | 65 | 53 | 0 |
| 31 Dec 16 | 650 | 53 | 53 | 0 |
| 30 Sep 16 | 603 | 42 | 149 | 0 |
| 30 Jun 16 | 585 | 33 | 149 | 0 |
| 31 Mar 16 | 573 | 30 | 149 | 0 |
| 31 Dec 15 | 573 | 30 | 149 | 0 |
| 30 Sep 15 | 567 | 31 | 0 | 0 |
| 30 Jun 15 | 548 | 31 | 0 | 0 |
| 31 Mar 15 | 523 | 28 | 0 | 0 |
| 31 Dec 14 | 498 | 23 | 0 | 0 |
| 30 Sep 14 | 482 | 17 | 0 | 0 |
| 30 Jun 14 | 468 | 14 | 0 | 0 |
| 31 Mar 14 | 467 | 13 | 0 | 0 |
| 31 Dec 13 | 469 | 14 | 0 | 0 |
Kwaliteitswinsten: DEDI has high quality earnings.
Groeiende winstmarge: DEDI's current net profit margins (3.7%) are lower than last year (5.1%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: DEDI's earnings have grown significantly by 25.9% per year over the past 5 years.
Versnelling van de groei: DEDI's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: DEDI had negative earnings growth (-34.8%) over the past year, making it difficult to compare to the Healthcare industry average (16.3%).
Rendement op eigen vermogen
Hoge ROE: DEDI's Return on Equity (23.6%) is considered high.